Drugs

News and Updates about the regulations in Drugs and Pharma

FDA Greenlights Imfinzi for Treatment of Limited-Stage Small Cell Lung Cancer in the United States

The United States Food and Drug Administration (FDA) has approved AstraZeneca’s Imfinzi (durvalumab) for adult patients diagnosed with limited-stage small cell lung cancer (LS-SCLC) whose disease remains stable following a regimen of concurrent platinum-based chemotherapy and radiotherapy. The FDA’s decision […]

FDA Greenlights Imfinzi for Treatment of Limited-Stage Small Cell Lung Cancer in the United States Read More »

AIDCOC Appeals to Karnataka Government for Reinstatement of Suspended State Drugs Controller; Requests Comprehensive Investigation

The All India Drugs Control Officers’ Confederation (AIDCOC), representing the nation’s drug control officers, has expressed its alarm regarding the suspension of Karnataka’s state drugs controller. This action followed the deaths of four pregnant women from complications allegedly linked to

AIDCOC Appeals to Karnataka Government for Reinstatement of Suspended State Drugs Controller; Requests Comprehensive Investigation Read More »

Advanced Diagnostics, Genomic Testing & Mobile Health Revolutionizing Medical Services

Advanced diagnostics, genomic testing, and mobile health technologies are revolutionizing the way healthcare is delivered, especially in rural and underserved regions. These advancements promise to reduce healthcare costs and enhance health management for communities that are challenging to reach. Dinesh

Advanced Diagnostics, Genomic Testing & Mobile Health Revolutionizing Medical Services Read More »

Vaxcyte Initiates Phase 2 Trial for VAX-31 in Healthy Infants to Combat Invasive Pneumococcal Disease

Vaxcyte Inc, a pioneering company at the forefront of vaccine development, has revealed the commencement of its phase 2 trial for VAX-31 in healthy infants. This marks an important milestone as the first participants have received their initial doses. The

Vaxcyte Initiates Phase 2 Trial for VAX-31 in Healthy Infants to Combat Invasive Pneumococcal Disease Read More »

Neuranics Secures $700,000 in Seed Funding Round Headed by Inflection Point Ventures

Neuranics, a trailblazer in healthcare diagnostics, has garnered $700,000 in seed funding, predominantly supported by Inflection Point Ventures (IPV). These resources are earmarked for advancing their technological capabilities and clinical validations, propelling the startup on its journey to transform blood

Neuranics Secures $700,000 in Seed Funding Round Headed by Inflection Point Ventures Read More »

KPMG Study Reveals Life Sciences CEOs Optimistic About Growth and AI Investment Amid Economic Hurdles

KPMG’s recent study sheds light on the confidence life sciences CEOs hold regarding their company’s growth, even amidst dwindling belief in the industry, economic volatility, and AI implementation challenges, alongside net zero objectives. The KPMG 2024 Life Sciences CEO Outlook,

KPMG Study Reveals Life Sciences CEOs Optimistic About Growth and AI Investment Amid Economic Hurdles Read More »